Q2 2024 Blueprint Medicines Corp Earnings Call Transcript
Hello, everyone. At this time, I would like to welcome everyone to the Blueprint Medicines Second Quarter 2024 financial results conference call. My name is Bruno, and I'll be operating your call today. All lines have been placed on mute to prevent any background noise. (Operator Instructions) I'll now hand over to your host Jenna Cohen, please, you may begin your conference.
Thank you, Bruno. Good morning, everyone, and welcome to Blueprint Medicines' Second Quarter 2024 financial and operating results conference call. This morning we issued a press release which outlines the topics we plan to discuss today. You can access the press release as well as the slides that we'll be reviewing by going to the Investors section of our website at www.blueprintmedicines.com.
Joining me today are Kate Haviland, Chief Executive Officer; Philina Lee, Chief Commercial Officer;Christin Rossi, Chief Operating
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |